mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis

Autores da FMUP
Participantes de fora da FMUP
- Castells, M
Unidades de investigação
Abstract
[No abstract available]
Dados da publicação
- ISSN/ISSNe:
- 1097-6825, 0091-6749
- Tipo:
- Letter
- Páginas:
- 877-878
- Link para outro recurso:
- www.scopus.com
Journal of Allergy and Clinical Immunology Mosby Inc.
Citações Recebidas na Web of Science: 30
Citações Recebidas na Scopus: 33
Documentos
- Não há documentos
Filiações
Keywords
- Adult; Anaphylaxis; COVID-19; COVID-19 Vaccines; Female; Humans; Mast Cells; Mastocytosis, Systemic; RNA, Messenger; SARS-CoV-2; bnt 162b 2; CD2 antigen; histamine H1 receptor antagonist; histamine H2 receptor antagonist; interleukin 2 receptor alpha; montelukast; stem cell factor receptor; tozinameran; tryptase; messenger RNA; adult; anaphylaxis; bloating; bone marrow derived mast cell; case report; cell aggregation; clinical article; colic; coronavirus disease 2019; diarrhea; direct contact transmission; disease exacerbation; drug safety; drug tolerability; female; gastroesophageal reflux; gene mutation; human; indolent systemic mastocytosis; Letter; mast cell activation syndrome; middle aged; migraine; myalgia; nurse; osteopenia; premedication; priority journal; protein blood level; pruritus; skin defect; skin pruritus; urticaria pigmentosa; vaccination; administration and dosage; adverse event; anaphylaxis; immunology; mast cell; prevention and control; systemic mastocytosis; virol
Campos de estudo
Proyectos asociados
Airborne food and aeroallergens levels in healthcare settings. An unaccounted but potentially relevant source of exposure?
Investigador Principal: André Miguel Afonso de Sousa Moreira
Estudo Clínico Académico (Aeroallergens) . 2020
How exercise, physical activity and diet modulate immune and stress responses
Investigador Principal: André Miguel Afonso de Sousa Moreira
Estudo Clínico Académico . 2020
Citar a publicação
Rama T,Moreira A,Castells M. mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis. J. Allergy Clin. Immunol. 2021. 147(3):p. 877-878. IF:14,290. (1).